Division of Cardiology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Centre for Population Health Sciences, Lothian Place University of Edinburgh, UK.
J Hepatol. 2014 May;60(5):1040-5. doi: 10.1016/j.jhep.2014.01.009. Epub 2014 Jan 18.
BACKGROUND & AIMS: Approximately 50% of hypertensive patients have non-alcoholic fatty liver disease (NAFLD), but whether change in fatty liver status over time modifies risk of developing hypertension is uncertain. Our aim was to determine whether a change in fatty liver status (either development of new fatty liver, or resolution of existing fatty liver) over five years modified risk of incident hypertension at five year follow-up.
11,448 patients without hypertension were examined at baseline and at five year follow-up, using a retrospective cohort study design. Fatty liver status (absent or present) was assessed at baseline and follow-up using standard ultrasound criteria. Adjusted odds ratios (aOR) and 95% confidence intervals (CIs) for incident hypertension at follow-up were estimated controlling for potential confounders, compared to the reference group (patients who did not have fatty liver at either baseline or follow-up).
911 patients developed incident hypertension. Incident fatty liver developed during follow-up in 1418 patients and fatty liver at baseline resolved during follow-up in 684 patients. Developing incident fatty liver was associated with incident hypertension, even after adjustment for multiple confounders (aOR=1.60 (95% CI 1.30, 1.96; p<0.001). Further adjustment for change in body mass index between baseline and follow-up only slightly attenuated this association (aOR=1.36 (95% CI 1.10, 1.67; p=0.004). With resolution of fatty liver at follow-up, risk of incident hypertension was not different from the reference group (aOR=1.21 (95% CI 0.90, 1.63; p=0.21).
Development of incident fatty liver is associated with increased risk of hypertension.
大约 50%的高血压患者患有非酒精性脂肪性肝病(NAFLD),但随着时间的推移,脂肪肝状态的变化是否会改变高血压的发病风险尚不确定。我们的目的是确定在五年的随访中,脂肪肝状态的变化(新发或已存在的脂肪肝的发展或消退)是否会改变五年后发生高血压的风险。
采用回顾性队列研究设计,对 11448 例无高血压的患者进行基线和五年随访检查。使用标准的超声标准评估基线和随访时的脂肪肝状态(存在或不存在)。与参考组(基线和随访时均无脂肪肝的患者)相比,控制潜在混杂因素后,估计新发高血压在随访时的调整比值比(aOR)和 95%置信区间(CI)。
911 例患者发生新发高血压。1418 例患者在随访期间新发脂肪肝,684 例患者在随访期间脂肪肝从基线消退。即使在调整了多种混杂因素后,新发脂肪肝与新发高血压仍有关联(aOR=1.60(95%CI 1.30, 1.96;p<0.001)。进一步调整基线和随访之间的体重指数变化仅略微减弱了这种关联(aOR=1.36(95%CI 1.10, 1.67;p=0.004)。在随访时脂肪肝消退后,新发高血压的风险与参考组无差异(aOR=1.21(95%CI 0.90, 1.63;p=0.21)。
新发脂肪肝与高血压风险增加有关。